Polymyxin B vs Pyrrhocoricin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Polymyxin B is a cyclic lipopeptide antibiotic from Bacillus polymyxa that was approved in the 1960s and fell out of favor due to nephrotoxicity, but has experienced a major clinical resurgence as a last-resort treatment for carbapenem-resistant Gram-negative infections (Acinetob...
Calculate Polymyxin B dose →Pyrrhocoricin is a proline-rich antimicrobial peptide from the hemipteran insect Pyrrhocoris apterus (firebug). Unlike membrane-lytic AMPs, pyrrhocoricin exerts its effects by penetrating bacterial cells and interfering with intracellular targets, specifically the bacterial heat ...
Calculate Pyrrhocoricin dose →| Parameter | Polymyxin B | Pyrrhocoricin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | FDA Approved | Preclinical |
| Half-Life | 6-8 hours | Short |
| Typical Dose | 15,000-25,000 units/kg/day IV | N/A (research only) |
| Frequency | Every 12 hours IV | N/A |
| Route | IV / IM / Topical / Intrathecal | Systemic (research) |
| FDA Status | Approved (systemic Gram-negative infections) | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.